基因检测对优化治疗复发性抑郁症患者的贡献
Rita Ioana Platona1,2, Florica Voiță-Mekeres2,3, Cristina Tudoran4,5,6
1Doctoral School, University of Medicine and Pharmacy "Victor Babes" Timisoara, 300041 Timisoara, Romania.
Clinics and practice
|May 28, 2024
概括
药物遗传学引导的抗抑郁药疗法显著改善了复发性抑郁障碍 (RDD) 患者的抑郁症状. 基因检测使得量身定制的治疗成为可能,导致与传统治疗相比,症状减轻效果更好.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 遗传学 遗传学 是一个
背景情况:
- 复发性抑郁障碍 (RDD) 在长期管理方面构成了重大挑战.
- 传统的抗抑郁药疗法可以具有可变的疗效.
- 药物遗传学为优化治疗结果提供了一个潜在的途径.
研究的目的:
- 评估药物遗传学引导抗抑郁药治疗对12个月内抑郁症状严重性的影响.
- 为了比较药物遗传学引导治疗与RDD患者常规治疗的疗效.
- 基于基因检测,分析抑郁和焦虑症状的长期演变.
主要方法:
- 一项前性纵向研究涉及76名患有RDD的患者,从2019年至2022年进行.
- 患者被分为药物遗传学引导组 (n=37) 和常规治疗组 (n=39).
- 使用汉密尔顿抑郁评分表 (HAM-D),汉密尔顿焦虑评分表 (HAM-A) 和临床全球印象表在多个随访点 (1,3,6,12个月) 评估症状严重程度.
主要成果:
- 尽管患有更严重的基线抑郁症,但药物遗传组显示RDD症状严重程度在统计学上显著且逐渐减少 (p < 0.001).
- 基因检测结果与治疗结果有很大关系,解释了67.4%的差异.
- 与对照组相比,药物遗传学引导组在抑郁和焦虑症状方面表现出更好的改善.
结论:
- 药物遗传学测试是调整抗抑郁药治疗在RDD患者治疗反应不佳的宝贵工具.
- 根据遗传特征量身定制治疗导致抑郁症和焦虑症症状的持续和增强减少.
- 这种方法为改善复发性抑郁障碍的长期管理提供了一个有希望的策略.
相关概念视频
Human Genetics
559
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
559
Behavioral Genetics and Its Designs
353
Behavior genetics explores how genetic inheritance influences human behavior. It focuses on how genes, passed from parents to offspring, contribute to the development of behavioral traits and tendencies. This branch of genetics seeks to understand the complex interplay between inherited genetic factors and environmental influences in shaping our behaviors.
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
353
Depressive Disorders: Etiology
68
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
68
Genetic Screens
4.9K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.9K
Antidepressant Drugs: MAOIs and Other Agents
225
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
225
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


